Commentary [Targeting Opioid Receptors: A New Treatment for Brain Disorders]

E-ISSN： 1996-3181|9|2|128-128

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.2, 2010-04, pp. : 128-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders

By Hayashi Teruo Tsai Shang-Yi Mori Tomohisa Fujimoto Michiko Su Tsung-Ping

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 557-577

Informa Healthcare

Access to resources Recommend Favorite

New Approaches in the Treatment of Overactive Bladder: Targeting Adrenergic Receptors and Neurokinin Receptors

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 43-47

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4321-4334

Bentham Science Publishers

Access to resources Recommend Favorite

Lack of Regulatory Changes of μ-Opioid Receptors by 14-Methoxymetopon Treatment in Rat Brain. Further Evidence for Functional Selectivity

Current Pharmaceutical Design, Vol. 19, Iss. 42, 2013-12 ,pp. : 7348-7354

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of - and -opioid receptors in the potentiation of brain-stimulation reward

By Duvauchelle C.L. Fleming S.M. Kornetsky C.

European Journal of Pharmacology, Vol. 316, Iss. 2, 1996-12 ,pp. : 137-143

Elsevier

Access to resources Recommend Favorite